Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The epidemiology of oral human papillomavirus infection in healthy populations: a systematic review and meta-analysis
Human papillomavirus (HPV) is a potentially oncogenic sexually transmitted infection. As the
incidence of oropharyngeal cancer (OPC) caused by oral HPV infections is rising, further …
incidence of oropharyngeal cancer (OPC) caused by oral HPV infections is rising, further …
Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination …
JJ Han, TH Beltran, JW Song, J Klaric, YS Choi - JAMA oncology, 2017 - jamanetwork.com
Importance Human papillomavirus (HPV) is a common sexually transmitted infection that is a
major cause of noncervical anogenital and oropharyngeal cancers. Prophylactic HPV …
major cause of noncervical anogenital and oropharyngeal cancers. Prophylactic HPV …
Multisite HPV infections in the United States (NHANES 2003–2014): An overview and synthesis
HPV is the most common sexually transmitted infection in the US, infecting both anogenital
and oral sites. Nationally representative data are collected through the National Health and …
and oral sites. Nationally representative data are collected through the National Health and …
Multinational epidemiological analysis of oral human papillomavirus incidence in 3,137 men
Oral human papillomavirus (HPV) is associated with oropharyngeal cancer (OPC). Although
OPC incidence is increasing globally, knowledge of oral HPV infection rates is limited. Here …
OPC incidence is increasing globally, knowledge of oral HPV infection rates is limited. Here …
[HTML][HTML] Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults
J Riddell IV, AF Brouwer, HM Walline… - Tumour Virus …, 2022 - Elsevier
Background HIV has been shown to increase the likelihood of oral HPV infection. In this
study, we evaluated the risk of oral HPV in HIV infected patients compared with HIV-negative …
study, we evaluated the risk of oral HPV in HIV infected patients compared with HIV-negative …
Cervical cancer screening and incidence by age: unmet needs near and after the stop** age for screening
MC White, ML Shoemaker, VB Benard - American journal of preventive …, 2017 - Elsevier
Introduction Leading professional organizations recommend cervical cancer screening for
average-risk women aged 21–65 years. For average-risk women aged> 65 years, routine …
average-risk women aged 21–65 years. For average-risk women aged> 65 years, routine …
[HTML][HTML] HPV16 DNA and integration in normal and malignant epithelium: implications for the etiology of laryngeal squamous cell carcinoma
X Chen, L Gao, EM Sturgis, Z Liang, Y Zhu, X **a… - Annals of …, 2017 - Elsevier
Background Molecular evidence suggests that human papillomavirus (HPV) has a role in
the etiology of oropharyngeal squamous cell carcinoma. However, the role of HPV in …
the etiology of oropharyngeal squamous cell carcinoma. However, the role of HPV in …
Prevalence and Determinants of Cervicovaginal, Oral, and Anal Human Papillomavirus Infection in a Population of Transgender and Gender Diverse People Assigned …
RD McIntosh, EC Andrus, HM Walline, CB Sandler… - LGBT health, 2024 - liebertpub.com
Purpose: The human papillomavirus (HPV) causes cervicovaginal, oral, and anogenital
cancer, and cervical cancer screening options include HPV testing of a clinician-collected …
cancer, and cervical cancer screening options include HPV testing of a clinician-collected …
Age effects and temporal trends in HPV-related and HPV-unrelated oral cancer in the United States: a multistage carcinogenesis modeling analysis
Differences in prognosis in HPV-positive and HPV-negative oral (oropharyngeal and oral
cavity) squamous cell carcinomas (OSCCs) and increasing incidence of HPV-related …
cavity) squamous cell carcinomas (OSCCs) and increasing incidence of HPV-related …
[HTML][HTML] High vaccine effectiveness persists for ten years after HPV16/18 vaccination among young Dutch women
J Hoes, AJ King, J Berkhof, HE de Melker - Vaccine, 2023 - Elsevier
The current study describes the long-term effectiveness of three-dose HPV16/18 vaccination
among Dutch women who were eligible for vaccination during a catch-up campaign and …
among Dutch women who were eligible for vaccination during a catch-up campaign and …